103 related articles for article (PubMed ID: 8826851)
1. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer.
Lehrer S; Terk M; Piccoli SP; Song HK; Lavagnini P; Luderer AA
Br J Cancer; 1996 Sep; 74(6):871-3. PubMed ID: 8826851
[TBL] [Abstract][Full Text] [Related]
2. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
4. [RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
Okubo Y; Ito T
Hinyokika Kiyo; 1999 Jan; 45(1):25-30. PubMed ID: 10086262
[TBL] [Abstract][Full Text] [Related]
5. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.
Cama C; Olsson CA; Raffo AJ; Perlman H; Buttyan R; O'Toole K; McMahon D; Benson MC; Katz AE
J Urol; 1995 May; 153(5):1373-8. PubMed ID: 7536252
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
8. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
[TBL] [Abstract][Full Text] [Related]
9. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
[TBL] [Abstract][Full Text] [Related]
10. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
[TBL] [Abstract][Full Text] [Related]
11. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
[TBL] [Abstract][Full Text] [Related]
12. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen in serum of women with breast cancer.
Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Levesque MA; Diamandis EP
Br J Cancer; 1995 Sep; 72(3):728-31. PubMed ID: 7545417
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.
Ghossein RA; Rosai J; Scher HI; Seiden M; Zhang ZF; Sun M; Chang G; Berlane K; Krithivas K; Kantoff PW
Urology; 1997 Jul; 50(1):100-5. PubMed ID: 9218026
[TBL] [Abstract][Full Text] [Related]
15. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival.
Wood DP; Banerjee M
J Clin Oncol; 1997 Dec; 15(12):3451-7. PubMed ID: 9396397
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583.
Halabi S; Small EJ; Hayes DF; Vogelzang NJ; Kantoff PW
J Clin Oncol; 2003 Feb; 21(3):490-5. PubMed ID: 12560440
[TBL] [Abstract][Full Text] [Related]
17. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.
Gao CL; Rawal SK; Sun L; Ali A; Connelly RR; Bañez LL; Sesterhenn IA; McLeod DG; Moul JW; Srivastava S
Clin Cancer Res; 2003 Jul; 9(7):2545-50. PubMed ID: 12855629
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy.
Ross RW; Manola J; Hennessy K; Galsky M; Scher H; Small E; Kelly WK; Kantoff PW
Clin Cancer Res; 2005 Jul; 11(14):5195-8. PubMed ID: 16033836
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer.
Kantoff PW; Halabi S; Farmer DA; Hayes DF; Vogelzang NA; Small EJ
J Clin Oncol; 2001 Jun; 19(12):3025-8. PubMed ID: 11408497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
